Ignite Creation Date:
2025-12-24 @ 1:19 PM
Ignite Modification Date:
2026-01-24 @ 8:19 AM
Study NCT ID:
NCT06125795
Status:
RECRUITING
Last Update Posted:
2025-09-29
First Post:
2023-10-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess Change in Functioning and Health Related Quality of Life in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Treatments in Routine Clinical Practice in Spain
Sponsor:
AbbVie
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Lymphocytic Leukemia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Chronic Lymphocytic Leukemia | View |
| None | Bruton Tyrosine Kinase Inhibitor | View |
| None | Patient-Reported Outcomes Measure | View |
| None | Patient-Reported Experience Measure | View |
| None | Venetoclax | View |
| None | Venclexta | View |
| None | Venclyxto | View |
| None | ABT-199 | View |
| None | Patient Preferences | View |
| None | Cancer | View |
| None | PROVIDENCE | View |